BioSpace News Archive

Dynamics Special Purpose Corp. (the “Company”) announced today the closing of its initial public offering of 23,000,000 shares of Class A common stock, which included the full exercise of the underwriters’ over-allotment option of 3,000,000 shares of Class A common stock.

Amgen (NASDAQ:AMGN) will present at the 2021 Jefferies Healthcare Conference at 1:30 p.m. ET on Thursday, June 3, 2021. Murdo Gordon, executive vice president of Global Commercial Operations at Amgen will present at the conference

Ongoing advancements in assistive reproductive technology and artificial insemination fuel the sperm processing media market

The vendor landscape in the global dental prosthetics market demonstrates a relatively consolidated structure, states a new report by Transparency Market Research (TMR).

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced it has closed a minority investment in Miromatrix, a biotechnology company working to eliminate the need for an organ transplant waiting list through the development of implantable engineered biological organs

Ryvu Therapeutics (WSE: RVU), a clinical stage drug discovery and development company focusing on novel small molecule therapies that address emerging targets in oncology, announced today that its Clinical Trial Application (CTA) to commence a single-agent, open-label Phase I/II trial, investigating the safety and efficacy of RVU120

Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise today announced that it has signed a Memorandum of Understanding with tella, Inc. (“tella”) to collaborate in the field of immunotherapy for cancer treatment.

Socionext Inc. has received a 21st “Technology Award” from the Japan Society of Ultrasonics in Medicine for the development of its handheld ultrasonic imaging system, the viewphii-US. The “Technology Award” is given annually to individuals or groups who develop new technologies and contribute to advancements in the field of ultrasonic medicine

Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group, confirms that the Annual Report and Accounts for the year ended 31 December 2020, the Notice of the Annual General Meeting (“AGM”) and a Form of Proxy were posted to shareholders today and are available on the Company’s website

Transparency Market Research in its new report predicts that the global metabolomics market will undergo a tremendous transformation in the near future.